HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone.

Abstract

MALT lymphoma is usually described in association with Helicobacter pylori, HCV, HHV8, Campylobacter jejuni or in a setting of overreactive immunity. In HIV(+) patients, MALT lymphoma is most commonly described in children. We describe here an original case of HIV(+) MALT lymphoma with bronchial, conjuctival and laryngeal involvement for which a clinical and histopathological remission has been obtained with HAART alone. We conclude that HIV, as well as H. pylori, C. jejuni and HCV can target lymphogenesis in MALT lymphoma.

• Authors: Thomas Girard, Isabelle Luquet-Besson, Fanny Baran-Marszak, Martine Raphaël, François Boué
• Journal: European journal of haematology (Eur J Haematol) Vol. 74 Issue 1 Pg. 70-2 (Jan 2005) ISSN: 0902-4441 [Print] England
• PMID: 15613110 (Publication Type: Case Reports, Journal Article)

Topics

• Antiretroviral Therapy, Highly Active
• Female
• Gene Rearrangement, B-Lymphocyte
• Humans
• Lymphoma, AIDS-Related (drug therapy, genetics, immunology, pathology)
• Lymphoma, B-Cell, Marginal Zone (complications, drug therapy, immunology, pathology)
• Middle Aged
• Remission Induction